Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 4Liver Neoplasms 1

Interventions

Sorafenib 8durvalumab 4Cisplatin 4Gemcitabine 3Ethiodized Oil 3Doxorubicin 3Chemotherapy, Adjuvant 3Bevacizumab 3tremelimumab 2sodium thiosulfate 2phosphomannopentaose sulfate 2Watchful Waiting 2Talaporfin 2Radiofrequency Ablation 2Oxaliplatin 2Nivolumab 2Folfox protocol 2Celecoxib 2Capecitabine 2Analgesia, Patient-Controlled 2seocalcitol 1parecoxib 1nolatrexed 1linifanib 1lenvatinib 1ferumoxides 1ferric carboxymaltose 1contrast agent BR1 1cabozantinib 1brivanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Liver Neoplasms × Embolization, Therapeutic × Clear all
NCT01229839 2019-03-06

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Sun Yat-sen University

Phase 3 Completed
668 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡